MX9706107A - Methods and uses for apoptin. - Google Patents
Methods and uses for apoptin.Info
- Publication number
- MX9706107A MX9706107A MX9706107A MX9706107A MX9706107A MX 9706107 A MX9706107 A MX 9706107A MX 9706107 A MX9706107 A MX 9706107A MX 9706107 A MX9706107 A MX 9706107A MX 9706107 A MX9706107 A MX 9706107A
- Authority
- MX
- Mexico
- Prior art keywords
- apoptin
- apoptosis
- normal cells
- tumor
- cells
- Prior art date
Links
Classifications
-
- E—FIXED CONSTRUCTIONS
- E04—BUILDING
- E04B—GENERAL BUILDING CONSTRUCTIONS; WALLS, e.g. PARTITIONS; ROOFS; FLOORS; CEILINGS; INSULATION OR OTHER PROTECTION OF BUILDINGS
- E04B5/00—Floors; Floor construction with regard to insulation; Connections specially adapted therefor
- E04B5/16—Load-carrying floor structures wholly or partly cast or similarly formed in situ
- E04B5/17—Floor structures partly formed in situ
- E04B5/23—Floor structures partly formed in situ with stiffening ribs or other beam-like formations wholly or partly prefabricated
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B28—WORKING CEMENT, CLAY, OR STONE
- B28B—SHAPING CLAY OR OTHER CERAMIC COMPOSITIONS; SHAPING SLAG; SHAPING MIXTURES CONTAINING CEMENTITIOUS MATERIAL, e.g. PLASTER
- B28B7/00—Moulds; Cores; Mandrels
- B28B7/0064—Moulds characterised by special surfaces for producing a desired surface of a moulded article, e.g. profiled or polished moulding surfaces
- B28B7/0085—Moulds characterised by special surfaces for producing a desired surface of a moulded article, e.g. profiled or polished moulding surfaces with surfaces for moulding chamfers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B28—WORKING CEMENT, CLAY, OR STONE
- B28B—SHAPING CLAY OR OTHER CERAMIC COMPOSITIONS; SHAPING SLAG; SHAPING MIXTURES CONTAINING CEMENTITIOUS MATERIAL, e.g. PLASTER
- B28B7/00—Moulds; Cores; Mandrels
- B28B7/10—Moulds with means incorporated therein, or carried thereby, for ejecting or detaching the moulded article
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B28—WORKING CEMENT, CLAY, OR STONE
- B28B—SHAPING CLAY OR OTHER CERAMIC COMPOSITIONS; SHAPING SLAG; SHAPING MIXTURES CONTAINING CEMENTITIOUS MATERIAL, e.g. PLASTER
- B28B7/00—Moulds; Cores; Mandrels
- B28B7/36—Linings or coatings, e.g. removable, absorbent linings, permanent anti-stick coatings; Linings becoming a non-permanent layer of the moulded article
-
- E—FIXED CONSTRUCTIONS
- E04—BUILDING
- E04B—GENERAL BUILDING CONSTRUCTIONS; WALLS, e.g. PARTITIONS; ROOFS; FLOORS; CEILINGS; INSULATION OR OTHER PROTECTION OF BUILDINGS
- E04B5/00—Floors; Floor construction with regard to insulation; Connections specially adapted therefor
- E04B5/02—Load-carrying floor structures formed substantially of prefabricated units
- E04B5/04—Load-carrying floor structures formed substantially of prefabricated units with beams or slabs of concrete or other stone-like material, e.g. asbestos cement
Landscapes
- Engineering & Computer Science (AREA)
- Architecture (AREA)
- Manufacturing & Machinery (AREA)
- Chemical & Material Sciences (AREA)
- Ceramic Engineering (AREA)
- Mechanical Engineering (AREA)
- Civil Engineering (AREA)
- Electromagnetism (AREA)
- Physics & Mathematics (AREA)
- Structural Engineering (AREA)
- Manufacturing Of Tubular Articles Or Embedded Moulded Articles (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Moulds, Cores, Or Mandrels (AREA)
- Rod-Shaped Construction Members (AREA)
- Forms Removed On Construction Sites Or Auxiliary Members Thereof (AREA)
- Building Environments (AREA)
Abstract
This invention describes that apoptin fails to induce apoptosis in human normal cells. Besides, the invention describes that when normal cells are transformed, they become susceptible to the apoptin-induced apoptosis. The invention describes that apoptin induces in various human tumor cells a p53-distinct type of apoptosis, and cannot be blocked by a variety of apoptosis-inhibiting agents. The invention comprises an anti-tumor agent, which specifically kill tumor and not normal cells. It further provides the induction of cell death by means of gene therapy. Apoptin can induce apoptosis in non-human animal tumor cells. The invention also provides that in normal cells apoptin was found predominantly in the cytoplasm, while in tumor cells it was located in the nucleus. Besides, the invention comprises a diagnostic test for the determination of cell-transforming activity.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9502383 | 1995-12-01 | ||
PCT/ES1996/000229 WO1997020666A1 (en) | 1995-12-01 | 1996-11-27 | Mold for prefabricated concrete panels |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9706107A true MX9706107A (en) | 1997-11-29 |
Family
ID=8292378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9706107A MX9706107A (en) | 1995-12-01 | 1996-11-27 | Methods and uses for apoptin. |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0818287B1 (en) |
DE (1) | DE69624226T2 (en) |
ES (1) | ES2179955T3 (en) |
MX (1) | MX9706107A (en) |
WO (1) | WO1997020666A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000077317A1 (en) * | 1999-06-09 | 2000-12-21 | Brentmuir Developments (1993) Limited | Concrete panel construction system |
US6698150B1 (en) | 1998-06-09 | 2004-03-02 | Brentmuir Developments (1993) Limited | Concrete panel construction system |
US7828544B2 (en) | 2004-11-26 | 2010-11-09 | Brentmuir Developments (1993) Limited | Concrete panel construction system and method of making panels |
US9399867B2 (en) | 2009-04-07 | 2016-07-26 | Millwick Acquisition Corp. | Concrete panel corner connection |
NL2004864C2 (en) * | 2010-06-09 | 2011-12-13 | Infra & B V | Moulds and methods for forming prefab concrete floor elements and prefab elements. |
WO2016183639A1 (en) | 2015-05-21 | 2016-11-24 | Lifting Point Pre-Form Pty Limited | A module for a structure |
CN108772944A (en) * | 2018-05-07 | 2018-11-09 | 安徽砼宇特构科技有限公司 | Convenient fixed mounting formula precast concrete case |
CN109176862B (en) * | 2018-11-09 | 2023-09-29 | 新疆博壹市政工程有限责任公司 | Manufacturing equipment structure and manufacturing method of ribbed prestressed prefabricated bottom plate |
CN114482375B (en) * | 2022-02-22 | 2023-07-28 | 杭州江润科技有限公司 | Construction method of integral joint type reinforced concrete superimposed sheet |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR886179A (en) * | 1942-08-29 | 1943-10-07 | Demoulding method and device | |
BE756509A (en) * | 1969-09-23 | 1971-03-01 | Haller Hans | FLOOR CONSISTING OF PREFABRICATED ELEMENTS JUXTAPOSED AND MOLDED, AND PROCESS FOR THEIR MANUFACTURING |
NL148528B (en) * | 1973-02-27 | 1976-02-16 | Kalkman Maschf En Handelsonder | DEVICE FOR THE MANUFACTURE OF A TILE WITH A CIRCULAR FACETED EDGE. |
DE3109108A1 (en) * | 1981-03-11 | 1982-09-23 | Karl Lösch KG, 6722 Lingenfeld | Moulded concrete slab with chamfer |
JPH02301404A (en) * | 1989-05-16 | 1990-12-13 | Okagaki Kogyo Kk | Descaling cleaning of steel concrete frame |
ES2076856B1 (en) * | 1993-03-03 | 1998-11-01 | Ruiz Miguel Camarero | CONSTRUCTION SYSTEM OF PREFABRICATED SEAT PLATES. |
DE4333080A1 (en) * | 1993-09-29 | 1995-03-30 | Ebawe Maschinenbau Gmbh | Mould for producing panel-like or slab-like precast concrete units |
-
1996
- 1996-11-27 MX MX9706107A patent/MX9706107A/en active IP Right Grant
- 1996-11-27 ES ES96939948T patent/ES2179955T3/en not_active Expired - Lifetime
- 1996-11-27 EP EP96939948A patent/EP0818287B1/en not_active Expired - Lifetime
- 1996-11-27 WO PCT/ES1996/000229 patent/WO1997020666A1/en active IP Right Grant
- 1996-11-27 DE DE69624226T patent/DE69624226T2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0818287B1 (en) | 2002-10-09 |
DE69624226D1 (en) | 2002-11-14 |
DE69624226T2 (en) | 2003-10-30 |
EP0818287A1 (en) | 1998-01-14 |
ES2179955T3 (en) | 2003-02-01 |
WO1997020666A1 (en) | 1997-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5913696A (en) | Methods and uses for apoptin | |
WO2002080754A3 (en) | Methods for using annexin for detecting cell death in vivo and treating associated conditions | |
DE69231245D1 (en) | CHANGED GENES IN HUMAN COLOREECTAL CANCER | |
TW200728465A (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
WO2004113571A3 (en) | Prostate specific genes and the use thereof as targets for prostate cancer therapy and diagnosis | |
WO1999040197A3 (en) | Variants of the angiogenic factor vascular endothelial cell growth factor: vegf | |
Litterst et al. | Comparative alterations in extrahepatic drug metabolism by factors known to affect hepatic activity | |
NO971557L (en) | TIE-2 ligands, method of preparation and use thereof | |
EP2279757A3 (en) | Compounds for targeting endothelial cells | |
AU2003219085A1 (en) | Methods for diagnosing and treating schizophrenia | |
MX9706107A (en) | Methods and uses for apoptin. | |
Krewski et al. | Potential health risks of radiofrequency fields from wireless telecommunication devices | |
WO2003016499A3 (en) | Combinatorial methods for inducing cancer cell death | |
AU7868300A (en) | Prostate cancer marker proteins | |
WO2000018961A3 (en) | Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer | |
WO1999028461A3 (en) | Methods and means for inducing apoptosis by interfering with bip-like proteins | |
WO2003098223A3 (en) | A method for killing cells by inhibiting histone activity in the cell | |
MX9709860A (en) | Methods and uses for apoptin. | |
AU6987696A (en) | The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells | |
Tatematsu et al. | Primary monoclonal and secondary polyclonal growth of colon neoplastic lesions in C3H/HeN→ BALB/c chimeric mice treated with 1, 2‐dimethylhydrazine: Immunohistochemical detection of C3H strain‐specific antigen and simple sequence length polymorphism analysis of DNA | |
WO2001004343A3 (en) | A method for determining the prognosis of cancer patients by measuring levels of bag expression | |
Li et al. | Determinates of tumor response to radiation: tumor cells, tumor stroma and permanent local control | |
Depuydt | The cellular response to different radiation qualities in relation to breast cancer screening and treatment | |
WO2005094267A3 (en) | Methods for regulating differentiation of neural cells and uses thereof | |
Martin et al. | Morphological transformation of C3H/M2 mouse fibroblasts by extracts of human mammary lipid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |